Back to calendar
Supernus Pharmaceuticals, Inc. (SUPN) Earnings
SUPN reports earnings on Tuesday, November 10, 2026
earnings report
November 10, 2026 · Before Market Open
Q3 2026
Est. EPS: $0.56
Actual EPS: $0.53
EPS surprise: 24.51%
Company overview
Market Cap$2.2B
PriceUSD 37.88
EPS (TTM)-1.91
52-week high59.68
52-week low37.54
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees778